Multi-institutional survey of cancer disparities in disabled patients in the region of northwestern Japan.

Cancer registration Cancer screening Disability Feasibility Hokushin region

Journal

International journal of clinical oncology
ISSN: 1437-7772
Titre abrégé: Int J Clin Oncol
Pays: Japan
ID NLM: 9616295

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 12 10 2020
accepted: 15 02 2021
pubmed: 2 3 2021
medline: 2 3 2021
entrez: 1 3 2021
Statut: ppublish

Résumé

Potential disparities between cancer patients with and without disabilities remained to be validate in Japan. We surveyed retrospective data on hospital cancer registration as well as information on disability certificates obtained through the Hokushin Ganpro database. In total, 93,545 cancer patients in 10 principal hospitals covering the region of northwestern Japan were registered with the Hokushin Ganpro database between 2010 and 2015. The database included the following data: diagnosis date, cancer type, staging, treatment, cancer detection process, and possession of a disability certificate. We found that 2983 patients, which accounted for 3.2% of the total patients, had disabilities. No significant differences in gender, age at diagnosis, cancer stage distribution, and cancer incidence rates were observed between the disabled and non-disabled patients. Even though the proportion of early-stage cancer among disabled patients differed only slightly from that in non-disabled patients, early-stage cancer was more frequently diagnosed in patients with disabilities during their regular hospital visits than in those without disabilities, who had more opportunity for early cancer detection during cancer screening. According to in-house data reflecting treatment period and process from a single hospital, all 16 disabled patients treated with chemotherapy completed the treatment until disease progression or end of predetermined cycles. These results indicate that deep disparities between cancer patients with and without disabilities are not apparent and that the disabled patients in the region of northwestern Japan receive appropriate hospital follow-up.

Sections du résumé

BACKGROUND BACKGROUND
Potential disparities between cancer patients with and without disabilities remained to be validate in Japan.
METHODS METHODS
We surveyed retrospective data on hospital cancer registration as well as information on disability certificates obtained through the Hokushin Ganpro database. In total, 93,545 cancer patients in 10 principal hospitals covering the region of northwestern Japan were registered with the Hokushin Ganpro database between 2010 and 2015. The database included the following data: diagnosis date, cancer type, staging, treatment, cancer detection process, and possession of a disability certificate.
RESULTS RESULTS
We found that 2983 patients, which accounted for 3.2% of the total patients, had disabilities. No significant differences in gender, age at diagnosis, cancer stage distribution, and cancer incidence rates were observed between the disabled and non-disabled patients. Even though the proportion of early-stage cancer among disabled patients differed only slightly from that in non-disabled patients, early-stage cancer was more frequently diagnosed in patients with disabilities during their regular hospital visits than in those without disabilities, who had more opportunity for early cancer detection during cancer screening. According to in-house data reflecting treatment period and process from a single hospital, all 16 disabled patients treated with chemotherapy completed the treatment until disease progression or end of predetermined cycles.
CONCLUSION CONCLUSIONS
These results indicate that deep disparities between cancer patients with and without disabilities are not apparent and that the disabled patients in the region of northwestern Japan receive appropriate hospital follow-up.

Identifiants

pubmed: 33646436
doi: 10.1007/s10147-021-01890-3
pii: 10.1007/s10147-021-01890-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1009-1014

Références

Iezzoni LI, Rao SR, Agaronnik ND et al (2020) Cross-sectional analysis of the associations between four common cancers and disability. J Natl Compr Cancer Netw JNCCN 18(8):1031–1044
doi: 10.6004/jnccn.2020.7551
Gulley SP, Rasch EK, Chan L (2014) Difference, disparity, and disability: a comparison of health, insurance coverage, and health service use on the basis of race/ethnicity among US adults with disabilities, 2006–2008. Med Care 52(10 Suppl 3):S9-16
doi: 10.1097/MLR.0000000000000129
Kim HW, Shin DW, Yeob KE et al (2020) Disparities in the diagnosis and treatment of gastric cancer in relation to disabilities. Clin Transl Gastroenterol 11(10):e00242
doi: 10.14309/ctg.0000000000000242
Peterson-Besse JJ, O’Brien MS, Walsh ES et al (2014) Clinical preventive service use disparities among subgroups of people with disabilities: A SCOPING review. Disabil Health J 7(4):373–393
doi: 10.1016/j.dhjo.2014.04.005
Ko KD, Lee KY, Cho B et al (2011) Disparities in health-risk behaviors, preventive health care utilizations, and chronic health conditions for people with disabilities: the Korean National Health and Nutrition Examination Survey. Arch Phys Med Rehabil 92(8):1230–1237
doi: 10.1016/j.apmr.2011.03.004

Auteurs

Shigeki Sato (S)

Division of Medical Oncology, Cancer Research Institute, Kanazawa University, 13-1, Takara-machi, Kanazawa, Ishikawa, 920-0934, Japan.

Azusa Tanimoto (A)

Division of Medical Oncology, Cancer Research Institute, Kanazawa University, 13-1, Takara-machi, Kanazawa, Ishikawa, 920-0934, Japan. atanimoto@staff.kanazawa-u.ac.jp.

Naohiro Yanagimura (N)

Division of Medical Oncology, Cancer Research Institute, Kanazawa University, 13-1, Takara-machi, Kanazawa, Ishikawa, 920-0934, Japan.

Chiaki Suzuki (C)

Division of Medical Oncology, Cancer Research Institute, Kanazawa University, 13-1, Takara-machi, Kanazawa, Ishikawa, 920-0934, Japan.

Yohei Takumi (Y)

Division of Medical Oncology, Cancer Research Institute, Kanazawa University, 13-1, Takara-machi, Kanazawa, Ishikawa, 920-0934, Japan.

Akihiro Nishiyama (A)

Division of Medical Oncology, Cancer Research Institute, Kanazawa University, 13-1, Takara-machi, Kanazawa, Ishikawa, 920-0934, Japan.

Kaname Yamashita (K)

Division of Medical Oncology, Cancer Research Institute, Kanazawa University, 13-1, Takara-machi, Kanazawa, Ishikawa, 920-0934, Japan.

Shinji Takeuchi (S)

Division of Medical Oncology, Cancer Research Institute, Kanazawa University, 13-1, Takara-machi, Kanazawa, Ishikawa, 920-0934, Japan.

Koushiro Ohtsubo (K)

Division of Medical Oncology, Cancer Research Institute, Kanazawa University, 13-1, Takara-machi, Kanazawa, Ishikawa, 920-0934, Japan.

Tomoe Makino (T)

Division of Adult Nursing Practice, Ishikawa Prefectural Nursing University, Kahoku, Japan.

Yoshio Yoshida (Y)

Department of Obstetrics and Gynecology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.

Yasuo Hirono (Y)

Cancer Care Promotion Center, University of Fukui Hospital, Fukui, Japan.

Ryuji Hayashi (R)

Clinical Oncology, Toyama University Hospital, Toyama, Japan.

Tomonobu Koizumi (T)

Department of Comprehensive Cancer Therapy, Shinshu University School of Medicine, Matsumoto, Japan.

Yozo Nakazawa (Y)

Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan.

Ken-Ichi Ito (KI)

Department of Breast and Endocrine Surgery, Shinshu University School of Medicine, Matsumoto, Japan.

Yoshiharu Motoo (Y)

Department of Medical Oncology, Kanazawa Medical University, Uchinada, Ishikawa, Japan.

Hidetaka Uramoto (H)

Department of Thoracic Surgery, Kanazawa Medical University, Uchinada, Ishikawa, Japan.

Mitsutoshi Nakada (M)

Department of Neurosurgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.

Yoshikazu Nishino (Y)

Department of Epidemiology and Public Health, Kanazawa Medical University, Uchinada, Ishikawa, Japan.

Seiji Yano (S)

Division of Medical Oncology, Cancer Research Institute, Kanazawa University, 13-1, Takara-machi, Kanazawa, Ishikawa, 920-0934, Japan.

Classifications MeSH